<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
</head>
<body style="word-wrap: break-word; -webkit-nbsp-mode: space; line-break: after-white-space;" class="">
<div class="" style="word-wrap: break-word; -webkit-nbsp-mode: space; line-break: after-white-space;">
<div class="" style="word-wrap: break-word; -webkit-nbsp-mode: space; line-break: after-white-space;">
IBIS Network - Week In Review
<div class="">February 18, 2022</div>
<div class=""><br class="">
</div>
</div>
</div>
<blockquote style="margin: 0 0 0 40px; border: none; padding: 0px;" class="">
<div class="" style="word-wrap: break-word; -webkit-nbsp-mode: space; line-break: after-white-space;">
<div class="" style="word-wrap: break-word; -webkit-nbsp-mode: space; line-break: after-white-space;">
<div class="">-IBIS-EP IRB Modification Approval:</div>
</div>
</div>
</blockquote>
<blockquote style="margin: 0 0 0 40px; border: none; padding: 0px;" class="">
<blockquote style="margin: 0 0 0 40px; border: none; padding: 0px;" class="">
<div class="" style="word-wrap: break-word; -webkit-nbsp-mode: space; line-break: after-white-space;">
<div class="" style="word-wrap: break-word; -webkit-nbsp-mode: space; line-break: after-white-space;">
<div class=""><span style="caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); font-family: Calibri, Arial, Helvetica, sans-serif;" class="">-Added CHLA as an IBIS-EP site</span></div>
</div>
</div>
</blockquote>
<blockquote style="margin: 0 0 0 40px; border: none; padding: 0px;" class="">
<div class="" style="word-wrap: break-word; -webkit-nbsp-mode: space; line-break: after-white-space;">
<div class="" style="word-wrap: break-word; -webkit-nbsp-mode: space; line-break: after-white-space;">
<div class=""><span style="caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); font-family: Calibri, Arial, Helvetica, sans-serif;" class="">-Updated the consent forms to include a new kit recovery policy for LENA </span></div>
</div>
</div>
</blockquote>
</blockquote>
<blockquote style="margin: 0 0 0 40px; border: none; padding: 0px;" class="">
<blockquote style="margin: 0 0 0 40px; border: none; padding: 0px;" class="">
<blockquote style="margin: 0 0 0 40px; border: none; padding: 0px;" class="">
<div class="" style="word-wrap: break-word; -webkit-nbsp-mode: space; line-break: after-white-space;">
<div class="" style="word-wrap: break-word; -webkit-nbsp-mode: space; line-break: after-white-space;">
<div class=""><font color="#000000" face="Calibri, Arial, Helvetica, sans-serif" class="">-New consents are in each site’s folder in the Document Repository</font></div>
<div class=""><font color="#000000" face="Calibri, Arial, Helvetica, sans-serif" class="">-UTD will reach out to the sites for information regarding the policy change</font></div>
</div>
</div>
</blockquote>
</blockquote>
</blockquote>
<div><br class="">
</div>
<div><br class="">
</div>
<div><br class="">
</div>
<div><br class="">
<blockquote type="cite" class="">
<div class="">On Feb 14, 2022, at 4:19 PM, Chappell, Chad <<a href="mailto:cchappel@med.unc.edu" class="">cchappel@med.unc.edu</a>> wrote:</div>
<br class="Apple-interchange-newline">
<div class="">
<div style="word-wrap: break-word; -webkit-nbsp-mode: space; line-break: after-white-space;" class="">
<div class="" style="word-wrap: break-word; -webkit-nbsp-mode: space; line-break: after-white-space;">
IBIS Network - Week In Review
<div class="">February 11, 2022</div>
<div class=""><br class="">
</div>
</div>
<blockquote style="margin: 0 0 0 40px; border: none; padding: 0px;" class="">
<div class="" style="word-wrap: break-word; -webkit-nbsp-mode: space; line-break: after-white-space;">
<div class="">-Guidelines have been adopted for terminology to be used in IBIS presentations/publications (February 2022)</div>
</div>
<div class="" style="word-wrap: break-word; -webkit-nbsp-mode: space; line-break: after-white-space;">
<div class=""><br class="">
</div>
</div>
</blockquote>
<blockquote style="margin: 0 0 0 40px; border: none; padding: 0px;" class="">
<blockquote style="margin: 0 0 0 40px; border: none; padding: 0px;" class="">
<div class="" style="word-wrap: break-word; -webkit-nbsp-mode: space; line-break: after-white-space;">
<div class="">-Given concerns raised by some in the autism community the IBIS Network has developed guidelines regarding use of the term ‘risk’ in IBIS presentations/publications. In the past we have used the terms ‘high risk (HR)’ and ‘low risk (LR)’ to refer
to infants who, respectively, have or do not have an older sibling with ASD. With this new guideline, we are now asking members of the Network to replace the term ‘risk’ with ‘likelihood’ and to qualify the term ‘likelihood’ with either the terms ‘high and
low’ or ‘higher and lower’, based on whichever fits best with the text. For example, sometimes the term ‘higher’ can be confusing without additional text, as it leaves the reader wondering ‘higher than what ?’. Similarly, some might be confused by the term
‘high’ when the intention is that this means higher than population risk and does not imply that a child is destined to develop autism. These are some of the pro and con arguments that have been presented in support of one or the other approach. Note: use
of a methods-based definition e.g., family history positive, in place of or in addition to using high/er and low/er likelihood, is acceptable.</div>
</div>
</blockquote>
</blockquote>
<div class="" style="word-wrap: break-word; -webkit-nbsp-mode: space; line-break: after-white-space;">
<div class=""><br class="">
</div>
</div>
<blockquote style="margin: 0 0 0 40px; border: none; padding: 0px;" class="">
<div class="" style="word-wrap: break-word; -webkit-nbsp-mode: space; line-break: after-white-space;">
<div class="">-Executive Committee Approvals</div>
</div>
<div class="" style="word-wrap: break-word; -webkit-nbsp-mode: space; line-break: after-white-space;">
<div class=""><br class="">
</div>
</div>
</blockquote>
<blockquote style="margin: 0 0 0 40px; border: none; padding: 0px;" class="">
<blockquote style="margin: 0 0 0 40px; border: none; padding: 0px;" class="">
<div class="" style="word-wrap: break-word; -webkit-nbsp-mode: space; line-break: after-white-space;">
<div class="">-Paper proposal: Gerig; Longitudinally-consistent Contrastive Self-supervision for One-shot Segmentation</div>
<div class=""><br class="">
</div>
<div class="">-<span style="caret-color: rgb(0, 0, 0);" class="">Paper proposal: Elison/Carolyn Lasch; </span><font class=""><span style="caret-color: rgb(0, 0, 0);" class="">characterizing longitudinal associations between temperament, higher-order RRBs, and
internalizing</span></font></div>
<div class=""><font class=""><span style="caret-color: rgb(0, 0, 0);" class=""><br class="">
</span></font></div>
<div class=""><font class=""><span style="caret-color: rgb(0, 0, 0);" class=""><br class="">
</span></font></div>
</div>
</blockquote>
</blockquote>
<div class=""><br class="">
<blockquote type="cite" class="">
<div class="">On Feb 4, 2022, at 4:54 PM, Chappell, Chad <<a href="mailto:cchappel@med.unc.edu" class="">cchappel@med.unc.edu</a>> wrote:</div>
<br class="Apple-interchange-newline">
<div class="">
<div style="word-wrap: break-word; -webkit-nbsp-mode: space; line-break: after-white-space;" class="">
IBIS Network - Week In Review
<div class="">February 4, 2022</div>
<div class=""><br class="">
</div>
<div class=""><br class="">
</div>
<blockquote style="margin: 0 0 0 40px; border: none; padding: 0px;" class="">
<div class="">-IBIS-SA sIRB Modification Approval:</div>
<blockquote style="margin: 0 0 0 40px; border: none; padding: 0px;" class="">
<blockquote class="" style="caret-color: rgb(0, 0, 0); font-family: LucidaGrande; margin: 0px 0px 0px 40px; border: none; padding: 0px;">
<br class="">
</blockquote>
</blockquote>
<blockquote style="margin: 0 0 0 40px; border: none; padding: 0px;" class=""><span style="caret-color: rgb(0, 0, 0); font-family: LucidaGrande;" class="">-University of Texas - Dallas was added to the IBIS-SA sIRB as an analysis site</span></blockquote>
<blockquote style="margin: 0 0 0 40px; border: none; padding: 0px;" class=""><font face="LucidaGrande" class=""><span style="caret-color: rgb(0, 0, 0);" class=""><br class="">
</span></font></blockquote>
<blockquote style="margin: 0 0 0 40px; border: none; padding: 0px;" class=""><span style="caret-color: rgb(0, 0, 0); font-family: LucidaGrande;" class="">-The Tasso device approved for use for iPSC blood collection</span></blockquote>
<blockquote style="margin: 0 0 0 40px; border: none; padding: 0px;" class="">
<blockquote class="" style="caret-color: rgb(0, 0, 0); font-family: LucidaGrande; margin: 0px 0px 0px 40px; border: none; padding: 0px;">
<div class="">
<div class="">
<div class=""><span class="">***2 consents updated for all data collection sites: </span></div>
</div>
</div>
</blockquote>
</blockquote>
<blockquote style="margin: 0 0 0 40px; border: none; padding: 0px;" class="">
<blockquote style="margin: 0 0 0 40px; border: none; padding: 0px;" class="">
<blockquote class="" style="caret-color: rgb(0, 0, 0); font-family: LucidaGrande; margin: 0px 0px 0px 40px; border: none; padding: 0px;">
<div class="">
<div class="">
<div class=""><span class=""><u class="">-iPSC Parent</u> and<u class=""> iPSC Assent
</u>have been uploaded to the Document Repository </span></div>
</div>
</div>
</blockquote>
</blockquote>
</blockquote>
<blockquote style="margin: 0 0 0 40px; border: none; padding: 0px;" class="">
<blockquote style="margin: 0 0 0 40px; border: none; padding: 0px;" class="">
<blockquote style="margin: 0 0 0 40px; border: none; padding: 0px;" class="">
<blockquote class="" style="caret-color: rgb(0, 0, 0); font-family: LucidaGrande; margin: 0px 0px 0px 40px; border: none; padding: 0px;">
<div class="">
<div class="">
<div class=""><span class="">-IBIS-SA IRB Documents>IBIS-SA Current Consents>All Sites Consents</span></div>
</div>
</div>
</blockquote>
</blockquote>
</blockquote>
</blockquote>
<blockquote style="margin: 0 0 0 40px; border: none; padding: 0px;" class=""><font face="LucidaGrande" class=""><span style="caret-color: rgb(0, 0, 0);" class=""><br class="">
</span></font></blockquote>
<blockquote style="margin: 0 0 0 40px; border: none; padding: 0px;" class=""><span style="caret-color: rgb(0, 0, 0); font-family: LucidaGrande;" class="">- DSSA data sharing with Cincinnati (Anna Esbensen) was approved</span></blockquote>
<blockquote style="margin: 0 0 0 40px; border: none; padding: 0px;" class="">
<blockquote class="" style="caret-color: rgb(0, 0, 0); font-family: LucidaGrande; margin: 0px 0px 0px 40px; border: none; padding: 0px;">
<div class="">
<div class="">
<div class=""><br class="">
</div>
</div>
</div>
</blockquote>
</blockquote>
<div class="">
<div class="">-IBIS Week In Review Archive for January has been uploaded to the Document Repository (under ‘IBIS Administrative Documents > IBIS_WeekInReview_January_2022’)</div>
</div>
<div class="">
<div class=""><span class="Apple-tab-span" style="white-space:pre"></span></div>
</div>
<blockquote style="margin: 0 0 0 40px; border: none; padding: 0px;" class="">
<div class="">-This document is searchable and will be updated each month</div>
</blockquote>
</blockquote>
<div class=""><br class="">
</div>
</div>
_______________________________________________<br class="">
Ace-recruitment mailing list<br class="">
<a href="mailto:Ace-recruitment@bic.mni.mcgill.ca" class="">Ace-recruitment@bic.mni.mcgill.ca</a><br class="">
<a href="https://mailman.bic.mni.mcgill.ca/mailman/listinfo/ace-recruitment" class="">https://mailman.bic.mni.mcgill.ca/mailman/listinfo/ace-recruitment</a><br class="">
</div>
</blockquote>
</div>
<br class="">
</div>
_______________________________________________<br class="">
Ace-recruitment mailing list<br class="">
<a href="mailto:Ace-recruitment@bic.mni.mcgill.ca" class="">Ace-recruitment@bic.mni.mcgill.ca</a><br class="">
https://mailman.bic.mni.mcgill.ca/mailman/listinfo/ace-recruitment<br class="">
</div>
</blockquote>
</div>
<br class="">
</body>
</html>